Heterozygous germline mutations in the FH are associated with hereditary leiomyomatosis and renal cell carcinoma (HLRCC), an autosomal dominant cancer syndrome that significantly increases the risk of developing type II papillary kidney cancer. Here, FH is linked to hereditary leiomyomatosis and renal cell cancer.